Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians

Journal of Clinical Virology

Volumn 43, Issue 1, 2008, Pages 25-31

  Dubey, Shweta ^a   Khalid, Mohammad ^a   Wesley, Clement ^a   Khan, Samir Ali ^a   Wanchu, Ajay ^b   Jameel, Shahid ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

CCR5; Co receptor downregulation; CXCR4; HIV; India

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; NEF PROTEIN; VPU PROTEIN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL LINE; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; INDIA; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INDIA; LYMPHOCYTE ACTIVATION; MALE; MONOCYTES; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RECEPTORS, CCR5; RECEPTORS, CXCR4;

EID: 49749150971     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.03.026     Document Type: Article

References (29)

1. Berger E.A., Murphy P.M., and Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism and disease. Annu Rev Immunol 17 (1999) 657-700
2. Bleul C.C., Wu L., Hoxie J.A., Springer T.A., and Mackay C.R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 94 (1997) 1925-1930
3. Brito A., Almeida A., Gonsalez C.R., Mendonca M., Ferreira F., Fernandes S.S., et al. Successful HAART is associated with high β-chemokine levels in chronic HIV type 1-infected patients. AIDS Res Hum Retroviruses 23 (2007) 906-912
4. Castedo M., Ferri K.F., Blanco J., Roumier T., Larochette N., Barretina J., et al. Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J Exp Med 194 (2001) 1097-1110
5. Cecilia D., Kulkarni S.S., Tripathy S.P., Gangakhedkar R.R., Paranjape R.S., and Gadkari D.A. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 271 (2000) 253-258
6. Chanel C., Staropoli I., Baleux F., Amara A., Valenzuela-Fernandez A., Virelizier J.L., et al. Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells. AIDS 16 (2002) 2337-2340
7. Chaudhry A., Das S.R., Hussain A., Mayor S., George A., Bal V., et al. The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs. J Immunol 175 (2005) 4566-4574
8. Chenine A.L., Sattentau Q., and Moulard M. Selective HIV-1-induced downmodulation of CD4 and coreceptors. Arch Virol 145 (2000) 455-471
9. Cicala C., Arthos J., Martinelli E., Censoplano N., Cruz C.C., Chung E., et al. R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells. Proc Natl Acad Sci USA 103 (2006) 3746-3751
10. Clerici M., Butto S., Lukwiya M., Saresella M., Declich S., Trabattoni D., et al. Immune activation in Africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project. AIDS 14 (2000) 2083-2092
11. Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo R.C., and Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270 (1995) 1811-1815
12. Davis C.B., Dikic I., Unutmaz D., Hill C.M., Arthos J., Siani M.A., et al. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 186 (1997) 1793-1798
13. Gorry P.R., Taylor J., Holm G.H., Mehle A., Morgan T., Cayabyab M., et al. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J Virol 76 (2002) 6277-6292
14. Hussain A., Das S.R., Tanwar C., and Jameel S. Oligomerization of the human immunodeficiency virus type 1 (HIV-1) Vpu protein-a genetic, biochemical and biophysical analysis. Virol J 4 (2007) 81
15. Jones D.H., McBride B.W., Roff M.A., and Farrar G.H. Efficient purification and rigorous characterization of a recombinant gp120 for HIV vaccine studies. Vaccine 13 (1995) 991-999
16. Michel N., Allespach I., Venzke S., Fackler O.T., and Keppler O.T. The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr Biol 15 (2005) 714-723
17. Napier K.B., Wang Z.X., Peiper S.C., and Trent J.O. CCR5 interactions with the variable 3 loop of gp120. J Mol Model 13 (2007) 29-41
18. Oppermann M. Chemokine receptor CCR5: insights into structure, function, and regulation. Cell Signal 16 (2004) 1201-1210
19. Ostrowski M.A., Justement S.J., Catanzaro A., Hallahan C.A., Ehler L.A., Mizell S.B., et al. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol 161 (1998) 3195-3201
20. Pakarasang M., Wasi C., Suwanagool S., Chalermchockcharoenkit A., and Auewarakul P. Increased HIV-DNA load in CCR5-negative lymphocytes without viral phenotypic change. Virology 347 (2006) 372-378
21. Pierdominici M., Giovannetti A., Ensoli F., Mazzetta F., Marziali M., De Cristofaro M.R., et al. Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr 29 (2002) 122-131
22. Ramalingam S., Kannangai R., Vijayakumar T.S., Subramanian S., Abraham O.C., Rupali P., et al. Increased number of CCR5+ CD4 T cells among south Indian adults probably associated with the low frequency of X4 phenotype of HIV-1 in India. Indian J Med Res 116 (2002) 90-95
23. Regoes R.R., and Bonhoeffer S. The HIV coreceptor switch: a population dynamical perspective. Trends Microbiol 13 (2005) 269-277
24. Rizzardini G., Piconi S., Ruzzante S., Fusi M.L., Lukwiya M., Declich S., et al. Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals. AIDS 10 (1996) 1535-1542
25. Ruibal-Ares B.H., Belmonte L., Bare P.C., Parodi C.M., Massud I., and de Bracco M.M. HIV-1 infection and chemokine receptor modulation. Curr HIV Res 2 (2004) 39-50
26. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76 (1994) 301-314
27. Stevceva L., Yoon V., Anastasiades D., and Poznansky M.C. Immune responses to HIV Gp120 that facilitate viral escape. Curr HIV Res 5 (2007) 47-54
28. Venzke S., Michel N., Allespach I., Fackler O.T., and Keppler O.T. Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection. J Virol 80 (2006) 11141-11152
29. Wei X., Decker J.M., Liu H., Zhang Z., Arani R.B., Kilby J.M., et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46 (2002) 1896-1905